Basiliximab in lung transplantation: Preliminary experience

Transplantation Proceedings

Volumn 37, Issue 3, 2005, Pages 1534-1536

  De La Torre, M ^a   Pena E ^a   Calvin, M ^a   Miguelez C ^a   Gonzalez D ^a   Fernandez R ^a   Molina, F ^a   Borro, J M ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZATHIOPRINE; BASILIXIMAB; CASPOFUNGIN; COTRIMOXAZOLE; CYCLOSPORIN; FLUCONAZOLE; GANCICLOVIR; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOSUPPRESSIVE AGENT; STEROID; TOBRAMYCIN; TUBERCULOSTATIC AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGED; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BACTERIAL INFECTION; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOMEGALOVIRUS INFECTION; DRUG SAFETY; EMPHYSEMA; FEMALE; GRAFT REJECTION; HUMAN; INCIDENCE; KIDNEY FUNCTION; LUNG CANCER; LUNG FIBROSIS; LUNG TRANSPLANTATION; LUNG TUBERCULOSIS; MALE; MYCOSIS; NONHUMAN; PNEUMOCYSTIS; PNEUMOCYSTOSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PSEUDOMONAS; SIDE EFFECT; SILICOSIS; STAPHYLOCOCCUS AUREUS; SURGICAL MORTALITY; TREATMENT INDICATION;

ANTIBODIES, MONOCLONAL; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFECTION; LUNG NEOPLASMS; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RECOMBINANT FUSION PROTEINS; RETROSPECTIVE STUDIES;

EID: 19044367470     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2005.02.026     Document Type: Conference Paper

References (10)

1. K. Bando, I.L. Paradis, S. Similo Obliterative bronchiolitis after lung and heart lung transplantation: an analysis of risk factors and management J Thorac Cardiovasc Surg 110 1995 4
2. J.D. Hosenpud, L.E. Bennett, B.M. Keck The registry of International Society of Heart and Lung Transplantation: eighteenth official report-2001 J Heart Lung Transplant 20 1995 805
3. V.G. Valentine, R.C. Robbins, G.J. Berry Actuarial survival of heart-lung and bilateral lung transplant recipients with obliterative bronchiolitis J Heart Lung Transplant 15 1996 371
4. B.D. Kahan, P.R. Rajagopalan, and M.L. Hall Reduction of the occurrence of acute cellular rejection among renal allograft recipients with Basiliximab, a chimeric anti-interleukin-2-receptor monoclonal antibody Transplantation 67 1999 276
5. C. Ponticelli, A. Yussim, V. Cambi A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients Transplantation 72 2001 1261
6. A. Dwomoa, P. Cockwell, N.J. Ives Interleukin-2 receptor monoclonal antibodies in renal transplantation: meta-analysis of randomised trials BMJ 326 2003 789
7. P. Neuhaus, P.A. Clavien, B. Nashan Improved treatment response with basiliximab immunoprophylaxis alter liver transplantation: results from double-blind randomized placebo-controlled trial Liver Transpl 8 2002 132
8. B. Hausen, J. Gummert, G.J. Berry Prevention of acute allograft rejection in nonhuman primate lung transplant recipients Transplantation 69 2000 488
9. M.N. Chariat, M. Erren, M. Chariat Basiliximab in the therapy of acute rejection after organ transplantation Transplant Proc 33 2001 2380
10. M.M. Aw, R.M. Taylor, A. Verma Basiliximab (Simulect) for the treatment of steroid-resistant rejection in pediatric liver transplant recipients: a preliminary experience Transplantation 75 2003 796